FDA approves Sotyktu for adults with active psoriatic arthritis

The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
MedPage Today

Not All Drugs Approved for Rheumatoid Arthritis Are Equal for Pain Relief

Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis (PsA), but their relative effects on pain, versus inflammation, are less ...

Common Arthritis Drug Found To Lower Blood Pressure and Boost Heart Health

A widely used treatment for rheumatoid arthritis may offer an unexpected cardiovascular benefit. Methotrexate has been a staple treatment for rheumatoid arthritis for decades, valued for its ability ...

Nine years to diagnosis: the challenge of spotting inflammatory arthritis and the role of first contact physiotherapists

Unlike osteoarthritis, inflammatory arthritis can begin at any age and damage joints quickly. Early diagnosis within three months improves outcomes.

Gut health supplement relieves arthritis pain, finds new study

A new study has found that a prebiotic fiber supplement reduced pain, improved grip strength, and lowered pain sensitivity in people with knee osteoarthritis (OA)—with far fewer dropouts than a ...
UPI

Study links diabetes drug to reduced arthritis pain in knees

A common diabetes drug can be repurposed to help overweight and obese people with knee arthritis, a new study says. Metformin reduced knee arthritis pain during a six-month treatment period, ...